Biotech & MedTech



Latest Comments
image_pdfimage_print

Drolet Stock Notes on IMV Inc.: A clinical stage company developing a first-in-class T cell targeted immune therapy for cancer

Mario Drolet, President of MI3 Communications Financières Inc. (MI3), released his Drolet Stock Notes on IMV Inc. (NASDAQ: IMV | […]


Brent Willis of Voyageur Pharmaceuticals discusses the high IRR and NPV in its recent PEA

In a recent InvestorIntel interview, Tracy Weslosky spoke with Brent Willis, President and CEO of Voyageur Pharmaceuticals Ltd. (TSXV: VM) about […]


The light at the end of the tunnel for Awakn Life Sciences addiction treatment by Psychedelic therapeutics

As an investor, I like to look for companies that have tremendous leverage to success. I often write about junior […]


Mike Druhan of MedX Health on the launch of its game changing DermSecure® Teledermatology platform

In a recent InvestorIntel interview, Tracy Weslosky spoke with Mike Druhan, President of Dermatology Services at MedX Health Corp. (TSXV: MDX) […]


Mike Druhan on MedX Health gaining revenue traction as it commercially launches its teledermatology platform

In a recent InvestorIntel interview, Mario Drolet spoke with Mike Druhan, President of Dermatology Services at MedX Health Corp. (TSXV: […]


Will Sixth Wave’s fast and accurate breathalyzer revolutionize global pathogenic virus testing?

I’m hopeful that we will soon see this whole COVID issue become an endemic as opposed to a pandemic, and […]


Voyageur Pharmaceuticals’ X-Ray Contrast Media Provides a Dramatic Increase in Valuation

Assuming you aren’t a meme stock or an equity driven by the Reddit army, then you know you’ve told the […]


Blender Bites is a Smooth(ie) Rapidly Growing Operator in the Frozen Health Food Category

Most people enter the new year full of optimism with thoughts of improving their health and wellness. Arguably you should […]


Bristow goes with technology and selects the stock to watch in 2022

Welcome to 2022! I’m cautiously optimistic that this will be the year we get to put Covid in the rear-view […]


David Regan on Sona Nanotech’s rapid-result saliva based COVID-19 test

In a recent InvestorIntel interview, Chris Thompson spoke with David Regan, CEO of Sona Nanotech Inc. (CSE: SONA | OTCQB: SNANF) […]